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Summary.-Comparisons have been made between (a) the initiation of tumours in
mouse skin, (b) the induction of hyperplasia and the suppression of sebaceous glands
in mouse skin and (c) the induction of s.c. tumours in rats, by either benzo[a]pyrene
or 7-methylbenz[a]anthracene and their related K-region and non-K-region di-
hydrodiols. Whilst the 3,4-dihydrodiol derived from 7-methylbenz[a]anthracene is
more active than the hydrocarbon in initiating tumours in mouse skin (subsequently
promoted by a phorbol ester) the7,8-dihydrodiol of benzo[a]pyrene is very much less
active than benzo[a]pyrene itself in the induction of hyperplasia or the suppression of
sebaceous glands in mouse skin or inthe induction ofs.c. sarcomasin rats. Since much
other evidence suggests that the 3,4-dihydrodiol of 7-methylbenz[a]anthracene and
the 7,8-dihydrodiol of benzo[a]pyrene are the dihydrodiols involved, via the related
vicinal diol-epoxides, in the metabolic activation of these hydrocarbons, mouse skin
initiation-promotion experiments may be more useful for the identification of such
diols than the other two in vivo tests for biological activity used here.
CERTAIN non-K-region dihydrodiols are
now thought to be involved, through their
conversion into the related vicinal diol-
epoxides, in the initiation of cancer by
polycyclic hydrocarbons such as benzo[a]
pyrene, 7-methylbenz[a]anthracene, 7,12-
dimethylbenz[a]anthracene and 3-methyl-
cholanthrene. The particular dihydrodiols
that are the precursors of reactive diol-
epoxides have been identified, partly
through the activities that they show as
mutagens (Wood et al., 1976; Malaveille
et al., 1977, 1978; Levin et al., 1978) and
as transforming agents (Marquardt et al.,
1977, 1978) in in vitro tests, partly by the
examination of the nucleic-acid adducts
that are formed when the parent hydro-
carbons are activated by metabolism in
tissues or in cultured cells (Sims et al.,
1974; Jeffrey et al., 1976, 1977; Grover et
al., 1976; Tierney et al., 1977; Bigger et al.,
1978) and partly by comparative in vivo
tests for biological activity (Slaga et al.,
1976; Chouroulinkov et al., 1976; Levin
et al., 1976). Since the non-K-region di-
hydrodiols are often available only in small
amounts, many of the in vivo tests have
been of tumour-initiating activity on
mouse skin using a phorbol ester as a
promoter, but other in vivo test procedures
may merit investigation. The results
presented here concern tests that have
been carried out on the activities of di-
hydrodiols derived from 7-methylbenz[a]
anthracene (I) or benzo[a]pyrene (II) (a)
as tumour-initiating agents on mouse
skin, (b) in the destruction of sebaceous
glands and the induction of hyperplasia
in mouse skin and (c) in the induction of
s.c. sarcomas in rats. A preliminary report
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of some of the interim results obtained
in one of these experiments has appeared
(Chouroulinkov et al., 1977).
MATERIALS AND METHODS
Chemicals.-Benzo[a]pyrene (Sigma Chemi-
cal Co., St Louis, Mo., U.S.A.) was purified
by column chromatography on alumina and
crystallization, and 7-methylbenz[a]anthra-
cene was prepared from benz[alanthracene
(Sims, 1967). trans-1,2-Dihydro-1,2-dihydroxy
-7-methylbenz[a]anthracene, trans-3,4-dihy-
dro - 3,4- dihydroxy - 7 - methylbenz[a]anthra-
cene and trans-8,9-dihydro-8,9-dihydroxy-
7-methylbenz[a]anthracene were obtained
from oxidations of the parent hydrocarbon
with an ascorbic acid-EDTA-ferrous sulphate
mixture and characterized as described
(Tierney et al., 1978), and trans-5,6-dihydro-
5,6 - dihydroxy - 7 - methylbenz[a]anthracene
and trans-4,5-dihydro-4,5-dihydroxybenzo[a]
pyrene were prepared from the corresponding
cis-isomers (Sims, 1967, 1970). trans-7,8-
Dihydro-7,8-dihydroxybenzo[alpyrene and
trans-9,10-dihydro-9,10-dihydroxybenzo[a] -
pyrene were prepared by published proce-
dures (McCaustland et al., 1976). 12-0-
Tetradecanoyl-phorbol- 13-acetate was very
kindly donated by Professor E. Hecker,
Heidelberg, Germany.
Initiation-promotion experiments.-Female
60-day-old CDI micethathad beenvaccinated
against ectromelia 14 days earlier were ran-
domized into groups of 30 and housed in
individual cages. The mice in each group
received a single dose (25 ,ug) of either 7-
methylbenz[a]anthracene or of one of the
4 related trans-dihydrodiols, which was
applied as a solution in acetone (0.05 ml) to
areas of dorsal skin that had been closely
clipped 48 h before treatment. A control group
of mice was treated with acetone alone.
Applications of the tumour-promoting agent,
12 - 0 - tetradecanoyl - phorbol - 13 - acetate
12 1
103
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II
(TPA), were begun 1 week after the applica-
tion of the initiator; for the first 26 weeks,
0 5 ,ug TPA/mouse was applied thrice weekly
as a solution in acetone (0.05 ml) and for the
succeeding 26 weeks thrice-weekly applica-
tions of 1 Hg TPA/mouse were made. The
total dose of TPA applied to the dorsal skin
of each mouse was 109-5 ,ug. All applications
of solutions of initiating and promoting sub-
stances were made with an automatic micro-
volumetric dispenser. Each animal was
examined regularly during the course of the
experiment, and the times of appearance of
papillomas and malignant neoplasms were
recorded; systematic postmortem examina-
tions were done, and followed by histological
examination of tissues where appropriate.
Short-term tests on mouse skin.-The pro-
cedure described by Guerin & Cuzin (1961)
and by Lazar et al. (1963, 1974) was followed.
Female45-day-old CDI mice wererandomized
into groups and housed individually. An
acetone solution (0.05 ml) of either benzo[a]
pyrene or of one of the 3 related trans-
dihydrodiols was then applied to an area of
dorsal skin that had been closely clipped 3
days earlier. The treatment was repeated on
alternate days until a total of 3 applications
of the test substance had been made to each
mouse; a control group was treated with 3
applications of acetone alone. Eight days
after the first treatment, the mice were killed
and the areas of treated skin fixed, sectioned
and stained for histological examination. The
thickness of the epidermis and the numbers
of sebaceous glands present were determined
in 2 microscopic fields of each of 6 sections
that were cut from each skin specimen. The
microscopic examinations were carried out
on code-numbered slides that carried no
details ofthe treatment given.
Subcutaneous effects in rats.-Female 6-
week-old Wistar rats (Evic-Ceba, Bordeaux,
France) were randomized into groups of 32
and housed 8 to a cage. The animals received
a single s.c. injection (0-9 mg) of either benzo-
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[a]pyrene or of one of the 3 related trans-
diols in olive oil (0 5 ml) in the dorsal region,
and were then kept under observation
without further treatment for up to 9 months.
Postmortem and histological examinations
were done when the animals died or were
killed.
RESULTS
The data from the mouse-skin tumour
initiation-promotion experiments using
either 7-methylbenz[a]anthracene or one of
the related trans-1,2-, trans-3,4-, trans-5,6
ortrans-8,9-dihydrodiolsasinitiatingagents
are given in Table I, which summarizes
information on the times at which tumours
appeared, on the numbers of mice bearing
tumours and on the frequency with which
neoplasms occurred in each group of
animals. Papillomas, the predominant
tumour type, started to appear about 10
weeksafterinitiation, asinprevious experi-
ments (Chouroulinkov et al., 1976), and
they appeared first in the group of mice
initiated with the 3,4-dihydrodiol. Only
5 malignant neoplasms were found, 4 of
which were squamous-cell carcinomas, and
the earliest examples ofthis type oftumour
were detected in mice initiated with the
3,4-dihydrodiol. The other malignant
tumour was a mixed-cell tumour that
contained both epithelial and fibroblastic
elements. At the termination of the
experiments, postmortem examinations
also revealed 13 animals with lung
adenomas, 1 with a uterine fibrosarcoma
and 1 with a thymic lymphoma, but the
distribution of animals bearing these
tumours did not appear to be related to
the treatments that the mice had received.
The skin-tumour incidence in the mice
initiated with the 3,4-dihydrodiol in-
creased sharply, but reached a plateau
at around 20 weeks after initiation; a
second plateau occurred after 40 weeks.
The numbers of tumours in the group of
mice initiated with 7-methylbenz[a]an-
thracene itself increased more regularly,
and showed only one plateau, after the
40th week. In contrast, tumour develop-
ment in the mice initiated with the
related 1,2- and 8-9-dihydrodiols only
really increased after the amount of TPA
applied had been doubled to 10 Hg per
application. The 5,6-dihydrodiol was al-
most without activity; after the amounts
of TPA applied were increased, 3 papil-
lomas appeared in this group, but 2 of
these later regressed.
The relative initiating activities of the
compounds tested were evaluated using
the x2 test, which confirmed that the
3,4-dihydrodiol was the most active com-
pound. Although the number of animals
with tumours was not significantly differ-
ent between the groups initiated with the
3,4-dihydrodiol and with the parent hydro-
carbon, the total number oftumoursresult-
ing from initiation by this diol is sig-
nificantly greater (P<0 05) than the
number in the group treated with 7-
methylbenz[a]anthracene. Other compari-
sons showed the 3,4-dihydrodiol to be
significantly more active than the corres-
ponding 1,2-, 5,6- and 8,9-dihydrodiols.
In the control group of mice that were
only treated with the phorbol ester, a
single papilloma was observed at the 17th
week, that later regressed. During the last
10 weeks of the experiment, 3 other papil-
lomas developed in this group after the
increased application of TPA.
The activities of benzo[a]pyrene in
the suppression of sebaceous glands and
the induction of hyperplasia in mouse
skin are compared with those of 3 related
dihydrodiols in Table II. Benzo[a]pyrene
itself suppressed sebaceous glands and
induced hyperplasia in a dose-dependent
manner, and the hydrocarbon was clearly
more active in both respects than any of
the 3 related dihydrodiols. The 7,8-
dihydrodiol showed some activity as a
hyperplastic agent and in the suppression
of sebaceous glands (Table II), but in
both cases was considerably less active
than benzo[a]pyrene. Hyperplasia was
not induced by either the 4,5- or the
9,10-dihydrodiols, and neither decreased
the numbers of sebaceous glands in
areas of treated mouse skin.
Benzo[a]pyrene and the related trans-
4,5-, 7,8- and 9,10-dihydrodiols were alsoBIOLOGICAL ACTIVITIES OF HYDROCARBON DIHYDRODIOLS
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TABLE II.-Development of epidermal hyperplasia and destruction of sebaceous glands in
mouse skin after treatment with benzo[a]pyrene (BP) or with a related dihydrodiol
Compound
BP
trans-4,5-Dihydro-
4,5-dihydroxy-BP
trans-7,8-Dihydro-
7,8-dihydroxy-BP
trans-9,1.0-Dihydro-
9,10-dihydroxy-BP
Dose*
(KLg)
75 0
112-5
150-0
75 0
112-5
150-0
750
112-5
150-0
750
112-5
150-0
No. of mice
30
20
17
30
30
15
30
30
10
30
30
19
Epidermal hyperplasiat
A
Thickness § % of control
21-5±2-37 182-2
29-4±4-18 249-2
43 0±5-16 372-2
11-0±0-78 93-2
11-7±1-17 99-2
12-6±2-27 106-8
19-3 ±2-21 163-6
19-7± 2-29 167-0
16-1±2-91 136-4
11-2+1-22 94-9
10-8± 0-92 91-5
10-9±1-05 92-4
Sebaceous glands4
No. present % destroyed
4-5±1-19 70-0
1-3±0-93 93-3
0.0 100-0
14-6±2-10 2-7
13-6±1-56 9-3
13 7±248 9-3
15-1±1-65
14-9±3-62
9 5±2-79 36-7
14-8 1-47
14-8± 1-38
14-6+ 1-48
Acetone 0-15ml 24 15-0±1-50 100-0 11-8±1-11
* Total dose applied in 3 applications, each of which contained the test compound as a solution in 0-05 ml
acetone.
t In 12 microscopic fields as described in the text.
$ In 12 microscopic fields of sections obtained as described in the text.
§ In arbitrary units.
tested for their abilities to induce sar-
comas after a single s.c. injection (0 9 mg)
into rats, and the results are given in
Table III. Sarcomas were induced in
24/30 rats treated with the hydrocarbon
itself, but the dihydrodiols were essentially
inactive. No s.e. tumours were detected
TABLE III. Induction of sarcomas after
s.c. injection of benzo[a]pyrene (BP) or
a related dihydrodiol into Wistar rats*
Compound
BP
tranis-4,5-Dihydro-
4,5-dihydroxy-BP
trans-7,8-Dihydro-
7,8-dihydroxy-BP
trans-9,10-Dihydro-
9,10-dihydroxy-BP
No. of
animals
30
32
32
32
No. with
sarcomas
24
* Female rats received the test compounds as a
single s.c. injection (0 9 mg) in 0 5 ml olive oil in the
dorsal region.
in the groups injected with either the
4,5- or the 9,10-dihydrodiols, and only
one sarcoma was induced in the group of
rats injected with the 7,8-dihydrodiol.
All the tumours that occurred were first
detected during the 6th month after the
injection. They were classical s.c. tumours
that evolved slowly, and the tumour-
bearing animals that died or were killed
8-9 months after the start of the experi-
ment carried large tumours. Postmortem
and histological examinations showed that
the tumours were fibrosarcomas with
well-limited margins that had not metasta-
sized; no other tumours were found in the
rats when the experiment was terminated
at 9 months.
DISCUSSION
The results (Table I) when 7-methyl-
benz[a]anthracene and 4 related dihydro-
diols were tested for tumour-initiating
activity on mouse skin clearly show that
the 3,4-dihydrodiol is more active in this
respect than the parent hydrocarbon,
which is itself more active than the related
1,2-, 5,6- and 8,9-dihydrodiols. The 10,11-
dihydrodiol was not tested in these experi-
ments because it was not available in
sufficient quantity. The 1,2- and 8,9-
dihydrodiols are, like the 3,4-dihydrodiol,
non-K-region diols that possess an isolated
double bond adjacent to the diol grouping
and they can in theory be converted intoBIOLOGICAL ACTIVITIES OF HYDROCARBON DIHYDRODIOLS
vicinal diol-epoxides: a diol-epoxide of
this type cannot be directly formed, how-
ever, from the K-region diol (the 5,6-
dihydrodiol), which was essentially devoid
oftumour-initiating activity in the present
experiments (Table I). The high initiating
activity of the 3,4-dihydrodiol is in agree-
ment with other data from biophysical
(Vigny et al., 1977), biochemical (Tierney
et al., 1977) and biological (Malaveille
et al., 1977; Marquardt et al., 1977)
studies, which together strongly suggest
that the metabolic activation of this
hydrocarbon involves the 3,4-dihydrodiol
and its conversion into the related vicinal
diol-epoxides, the isomeric 3,4-dihydro-
3,4 - dihydroxy - 7 - methylbenz[a]anthra-
cene, 1,2-oxides. 7-Methylbenz[a]anthra-
cene is metabolized by mouse skin to a
variety of hydroxylated products that
include the 3,4-dihydrodiol (Tierney et
al., 1977) and, in the present experiments,
the lower activity of the parent hydro-
carbon than of the 3,4-dihydrodiol, may
well reflect its metabolism by alternative
pathways.
The results reported here for dihydro-
diols derived from 7-methylbenz[a] anthra-
cene and those obtained previously for
diols derived from benzo[a]pyrene (Slaga
et al., 1976; Chouroulinkov et al., 1976;
Levin et al., 1976) and from benz[a]
anthracene (Levin et al., 1978) show that
comparative tests for mouse-skin tumour-
initiating activity can assist in the identi-
fication of the dihydrodiols that are
involved in the metabolic activation of
the parent hydrocarbons.
In contrast, the results when the activi-
ties of benzo[a]pyrene and of its related
dihydrodiols in the induction of hyper-
plasia and the suppression of sebaceous
glands in mouse skin and in the induction
of s.c. sarcomas in rats were examined
were not so encouraging. In these short-
term mouse skin tests (Table II), the 7,8-
dihydrodiol of benzo[a]pyrene, which has
shown biological activity equivalent to, or
higher than, that of benzo[a]pyrene itself
in a variety of other test systems (Mala-
veille et al., 1975; Slaga et al., 1976;
Chouroulinkov et al., 1976; Marquardt
et al., 1976), was clearly less active than
the parent hydrocarbon. The activities
of a range of polycyclic hydrocarbons in
inducing hyperplasia and in suppressing
sebaceous glands have been reported to
correlate with their carcinogenic potencies
(Bock & Mund, 1958; Gue'rin & Cuzin,
1961; Lazar & Chouroulinkov, 1974).
Somewhat similar results were obtained
when the carcinogenic activities of benzo-
[a]pyreneandtherelateddihydrodiols were
compared after their s.c. injection into rats
(Table III). Although the 7,8-dihydrodiol
produces tumours in mouse skin, and is
as active in this respect as the parent
hydrocarbon, it was very much less active
than benzo[a]pyrene as an s.c. carcinogen
in rats. Since it has been shown that short-
term skin tests in mice are more relevant
to the promoting activities of chemicals
(Lazar & Chouroulinkov, 1974) and since
the induction of s.c. sarcomas in rats
appears to be related to the abilities of
chemicals to act as complete carcinogens,
the lack of activity shown by the 7,8-
dihydrodiol of benzo[a]pyrene in these
tests and the high activity that it has
shown in other test systems suggests that
it may be more effective as an initiating
agent than as a complete carcinogen.
However, this explanation requires experi-
mental confirmation, and the differences
between the activities of benzo[a]pyrene
and of the related 7,8-dihydrodiol in the
two test systems examined here may be
due to pharmacokinetic differences in
the metabolism of these compounds in
these situations. Of the 3 test systems
examined here, therefore, only the mouse
skin initiation-promotion experiments
have given results that are in broad agree-
ment with the other available information
that has identified the 7,8-dihydrodiol of
benzo[a]pyrene and the 3,4-dihydrodiol
of 7-methylbenz[a]anthracene as the di-
hydrodiols that are, through conversion
into reactive bay-region vicinal diol-
epoxides, important in the metabolic
activation ofthese two carcinogenic hydro-
carbons.
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